GAMMA KNIFE:
BRAIN RADIOSURGERY
A complete guide to Gamma Knife radiosurgery โ the gold standard for intracranial SRS, using 192 focused cobalt gamma beams to treat brain metastases, meningiomas, acoustic neuromas, AVMs, and other targets with sub-millimetre accuracy in 1-5 sessions.
analyticsAt a Glance
- check_circleGamma Knife uses 192 focused gamma ray beams converging on a single intracranial point โ each beam harmless alone, combined at the target the dose is ablative.
- check_circle90-97% 10-year local control for meningioma and acoustic neuroma โ with 98% facial nerve preservation and hearing preservation in selected patients.
- check_circleNo incision, no anaesthesia required for most adults โ fully non-invasive outpatient or day-case treatment.
- check_circleAvailable at Apollo, Fortis, and AIIMS in India (USD 4,000-10,000) and at major Chinese neurosurgical centres.
What Is Gamma Knife Radiosurgery?
Gamma Knife radiosurgery is a highly precise, non-invasive form of radiation therapy using 192 finely focused cobalt-60 gamma ray beams converging on a specific target inside the brain. Despite the name, no surgical incision is made. Each gamma ray beam carries minimal energy through healthy brain tissue โ but where all 192 converge precisely on the target, the combined dose is ablative.
โEach of the 192 beams is too weak to harm healthy brain tissue on its own โ it is only at their convergence point that the combined dose destroys the tumour.โ
Sub-Millimetre Accuracy
Modern Gamma Knife systems (including the Elekta Icon) target lesions with sub-millimetre accuracy. This level of precision makes Gamma Knife particularly valuable in critical brain locations where conventional surgery carries significant neurological risk.
How It Differs from Conventional Radiotherapy
Conventional radiotherapy delivers radiation over 25-35 daily sessions, treating a broader area. Gamma Knife delivers a much higher dose to a precisely defined small target in 1-5 sessions. The combination of very high dose and very small target volume achieves local ablation with minimal exposure to surrounding normal brain.
Gamma Knife Icon โ Modern Platform
The Gamma Knife Icon introduced frameless mask-based immobilisation alongside the traditional invasive head frame, a high-definition cone-beam CT for daily position verification, and online adaptive correction. This enables fractionated treatment over several sessions โ beneficial for larger lesions or those adjacent to critical structures.
Gold Standard for Intracranial SRS
Gamma Knife has the longest track record of any intracranial radiosurgery system โ more than 50 years of clinical use and the largest published evidence base. For brain metastases, meningiomas, acoustic neuromas, and AVMs, it is the most widely referenced comparator in radiosurgery studies.
What Conditions Is Gamma Knife Used to Treat?
Gamma Knife is used primarily for intracranial targets โ tumours, vascular malformations, and functional conditions within the brain and skull base.
Brain Metastases
The most common indication. Brain metastases from lung, breast, melanoma, colon, renal cell, and other primaries. Gamma Knife treats 1-10 lesions in a single session, preserving neurocognitive function versus whole-brain radiation. JCOG 0504, N0574, and N107C trials established Gamma Knife as equivalent or superior to WBRT for limited brain metastases.
Meningioma
Slow-growing tumours near the skull base, cavernous sinus, or optic structures where surgery carries high risk. Gamma Knife achieves 90-95% 10-year local control for small to medium meningiomas with a low side effect profile โ increasingly used as first-line treatment for incidental and symptomatic meningiomas.
Acoustic Neuroma (Vestibular Schwannoma)
Non-cancerous tumours of the hearing and balance nerve. Gamma Knife achieves 92-97% 10-year tumour control with 98% facial nerve preservation and 50-70% hearing preservation โ now the preferred modality over surgery for tumours under 3 cm where hearing preservation is the goal.
Pituitary Adenoma
Used when surgical access is limited, for residual post-surgical tumour, or when surgery would carry unacceptable risk. Effective for both functioning (hormone-secreting) and non-functioning adenomas.
Arteriovenous Malformation (AVM)
Gamma Knife does not immediately destroy AVMs but triggers progressive vessel obliteration over 2-3 years. Used for AVMs in eloquent brain areas where surgery would be too risky. Obliteration rates of 80-90% at 3-5 years for small AVMs.
Key Evidence Numbers
- 90-97%10-Year Local Control โ Acoustic NeuromaWith 98% facial nerve preservation. Gamma Knife vs microsurgery: comparable control, lower immediate morbidity.
- 90-95%10-Year Local Control โ MeningiomaSmall to medium skull base and cavernous sinus meningiomas at experienced centres.
- 93-97%1-Year Local Control โ Brain MetastasesPer-lesion local control rate for lesions treated with SRS alone across major prospective series.
- 1-5Treatment SessionsSingle fraction SRS for most indications; 2-5 fractions for larger lesions or critical structure proximity.
Gamma Knife SRS vs Whole-Brain Radiation Therapy (WBRT)
For 1-10 brain metastases in patients with good performance status, randomised trial evidence strongly favours SRS over WBRT.
Gamma Knife SRS (Preferred)
- Equivalent or better overall survivalJCOG 0504, NCCTG N0574, N107C: SRS non-inferior to WBRT for survival in all major randomised trials.
- Significantly better neurocognitive functionN0574: SRS significantly better cognitive function at 3 months vs WBRT.
- Better quality of lifeN107C: significantly better quality of life with SRS after resected brain metastases.
- Preserves retreatment optionsAfter Gamma Knife, future SRS at new or progressing sites remains possible. Not possible after WBRT.
WBRT (Reserved for Specific Scenarios)
- More than 10-15 brain metastasesWhen number or total tumour volume makes individual SRS treatment impractical.
- Leptomeningeal metastasesDiffuse leptomeningeal spread requires whole-brain coverage.
- Very small lesions not visualised on planning MRIMicroscopic disease requires broad-field treatment.
- Patient preference or logisticsSingle-session WBRT may be preferred in patients with very limited life expectancy and performance status.
Gamma Knife Treatment Costs: India and China vs USA
Gamma Knife requires significant capital investment. India and China offer the same Elekta technology at 70-85% lower cost.
Gamma Knife SRS โ Single Brain Metastasis
- India (Apollo, Fortis, AIIMS)USD 4,000-8,000
- China (Tiantan, Huashan, major centres)USD 4,000-9,000
- USAUSD 20,000-45,000
Gamma Knife SRS โ Acoustic Neuroma
- IndiaUSD 5,000-10,000
- ChinaUSD 5,000-12,000
- USAUSD 25,000-50,000
Related Guides in the Radiation Therapy Library
Explore related radiosurgery and radiation therapy content.
Frequently Asked Questions
About Gamma Knife Treatment
Is Gamma Knife surgery actual surgery?
No. The term 'surgery' in 'radiosurgery' refers to surgical precision, not a surgical incision. No cuts are made, no anaesthesia is required for most adult patients, and most patients go home the same day. The 192 focused gamma ray beams converge on the target from outside the skull with sub-millimetre accuracy.
How many Gamma Knife sessions are needed?
Most Gamma Knife treatments are delivered in a single session (single-fraction SRS), typically taking 1-4 hours including setup, imaging, and treatment. For larger lesions, lesions near critical structures (optic nerves, brainstem), or when fractionation is clinically beneficial, the Gamma Knife Icon platform allows treatment over 2-5 sessions using a frameless mask system.
Is Gamma Knife available in India?
Yes. Gamma Knife systems are installed at Apollo Cancer Centres (multiple cities), Fortis Memorial Research Institute (Gurgaon), All India Institute of Medical Sciences (Delhi), Jaslok Hospital (Mumbai), and several other centres. India offers Gamma Knife at approximately USD 4,000-10,000 per treatment depending on lesion complexity, compared to USD 20,000-50,000 in the United States.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Is Gamma Knife Radiosurgery Right for Your Brain Tumour?
Upload your MRI and pathology reports โ our radiation oncology team will review your case and provide an honest assessment of Gamma Knife eligibility and the best centre for your specific indication.
This content is for informational purposes only and does not constitute medical advice. All treatment decisions must be made in consultation with a qualified radiation oncologist.